NCT07480564Phase 3Active not recruiting

Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome

Study sponsor: Taysha Gene Therapies, Inc. · TSHA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2031-06Estimated
Enrollment · participants4Actual
Source updated2026-08-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 3 participants (planned). After: 4 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source